DHBUF (Delivra Health Brands) Interest Expense: $-0.07 Mil (TTM As of Mar. 2026)

What is Delivra Health Brands Interest Expense?

Delivra Health Brands DHBUF -0.29% 28 Interest Expense is $-0.07 Mil as of Mar. 2026. GuruFocus rates DHBUF with a GF Score™ of 28/100 and a GF Value™ of $0.19 (Possible Value Trap). The stock has 3 warning signs investors should review.

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Delivra Health Brands's interest expense for the three months ended in Mar. 2026 was $ -0.05 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2026 was $-0.07 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Delivra Health Brands's Operating Income for the three months ended in Mar. 2026 was $ -0.71 Mil. Delivra Health Brands's Interest Expense for the three months ended in Mar. 2026 was $ -0.05 Mil. Delivra Health Brands did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Delivra Health Brands (OTCPK:DHBUF) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Delivra Health Brands's Interest Expense for the three months ended in Mar. 2026 was $-0.05 Mil. Its Operating Income for the three months ended in Mar. 2026 was $-0.71 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2026 was $1.47 Mil.

Delivra Health Brands's Interest Coverage for the quarter that ended in Mar. 2026 is calculated as

Delivra Health Brands did not have earnings to cover the interest expense.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Delivra Health Brands Interest Expense Historical Data

* Premium members only.

The historical data trend for Delivra Health Brands's Interest Expense can be seen below:

Delivra Health Brands Interest Expense Chart

Delivra Health Brands Annual Data

Trend

Dec16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Jun25

Interest Expense

Get a 7-Day Free Trial

0.00

-0.50

-0.19

-0.12

-0.09

Delivra Health Brands Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
Interest Expense	Get a 7-Day Free Trial															-0.05	0.08	-0.05	-0.05	-0.05

28GF Score

Delivra Health Brands Inc DHBUF

Interest Expense is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Delivra Health Brands Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.07 Mil.

Frequently Asked Questions Learn more about Interest Expense →

What does a Interest Expense of $-0.07 Mil mean?

Delivra Health Brands (DHBUF) has a Interest Expense of $-0.07 Mil as of Mar. 2026. Interest Expense is the amount a company pays on its long-term debt. View historical data on Delivra Health Brands and its competitors.

Is Delivra Health Brands' Interest Expense too high?

Delivra Health Brands' current Interest Expense is $-0.07 Mil. Overall, Delivra Health Brands has a GF Score™ of 28/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.

How does Delivra Health Brands' Interest Expense compare to ZTS and UTHR?

Delivra Health Brands' Interest Expense of $-0.07 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Interest Expense for a Drug Manufacturers company?

A good Interest Expense depends on the Drug Manufacturers industry context. However, Interest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Interest Expense mean?

A high Interest Expense can signal that a stock is expensive relative to its fundamentals. Interest Expense is the amount a company pays on its long-term debt. View historical data on Delivra Health Brands and its competitors. Delivra Health Brands's current Interest Expense is $-0.07 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Delivra Health Brands stock overvalued right now?

Based on GuruFocus' analysis, Delivra Health Brands (DHBUF) is currently considered Possible Value Trap. The stock's GF Value™ is $0.19, compared to a current price of $0.07 — trading 63.2% below its estimated fair value. The current Interest Expense is $-0.07 Mil. Delivra Health Brands' overall GF Score™ is 28/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Interest Expense calculated?

Interest Expense is calculated from a company's financial statements. For Delivra Health Brands (DHBUF), the current Interest Expense is $-0.07 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Delivra Health Brands (DHBUF) Overvalued in 2026?

Based on GuruFocus' analysis, Delivra Health Brands stock appears to be undervalued. The current stock price of $0.07 is trading 63.2% below its estimated GF Value™ of $0.19. GuruFocus considers Delivra Health Brands to be Possible Value Trap.

Key valuation signals for DHBUF:

Interest Expense: $-0.07 Mil
GF Value™: $0.19 vs. price of $0.07 (63.2% below fair value)
GF Score™: 28/100 with 3 warning signs

No single metric tells the full story. See the DHBUF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Delivra Health Brands Business Description

Industry Healthcare Drug Manufacturers

Comparable Companies TSXV:ELXR.H XCNQ:PLCN XCNQ:TGIF XCNQ:CVGR XCNQ:RAMM XCNQ:CRCC XCNQ:PHRX XCNQ:BBM XCNQ:VENI XCNQ:STKT XTER:MRK XSWX:GALD TSE:4502 SHSE:600276 NSE:SUNPHARMA LSE:HLN XTAE:TEVA XSWX:SDZ ZTS UTHR

Other Exchanges 3F0:Germany DHB:Canada

Address 999 Canada Place, Suite 404, Vancouver, BC, CAN, V6C 3E2

Website https://www.delivrahealthbrands.com

Delivra Health Brands Inc helping people take control of health with alternative wellness solutions. Its portfolio features brands like Dream Water and LivRelief that deliver relief from common, everyday issues like chronic pain, anxiety, and sleeplessness. The principal activities of the company are to provide lifestyle and health and wellness products to consumers and patients in regulated markets. The company geographically operates in Canada and United States, out of which it generates maximum revenue from Unites States.

28GF Score

Get the complete analysis for DHBUF

Interest Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.07

Price

$0.19

GF Value

View DHBUF Analysis

See Interest Expense data for all stocks →